Results 41 to 50 of about 400,933 (233)

Prediction of drug–target binding affinity using similarity-based convolutional neural network

open access: yesScientific Reports, 2021
Identifying novel drug–target interactions (DTIs) plays an important role in drug discovery. Most of the computational methods developed for predicting DTIs use binary classification, whose goal is to determine whether or not a drug–target (DT) pair ...
Jooyong Shim   +3 more
doaj   +1 more source

DGDTA: dynamic graph attention network for predicting drug–target binding affinity

open access: yesBMC Bioinformatics, 2023
Background Obtaining accurate drug–target binding affinity (DTA) information is significant for drug discovery and drug repositioning. Although some methods have been proposed for predicting DTA, the features of proteins and drugs still need to be ...
Haixia Zhai   +5 more
doaj   +1 more source

Discovering the Biological Target of 5-epi-Sinuleptolide Using a Combination of Proteomic Approaches

open access: yesMarine Drugs, 2017
Sinuleptolide and its congeners are diterpenes with a norcembranoid skeleton isolated from the soft coral genus Sinularia. These marine metabolites are endowed with relevant biological activities, mainly associated with cancer development.
Elva Morretta   +5 more
doaj   +1 more source

ELECTRA-DTA: a new compound-protein binding affinity prediction model based on the contextualized sequence encoding

open access: yesJournal of Cheminformatics, 2022
Motivation Drug-target binding affinity (DTA) reflects the strength of the drug-target interaction; therefore, predicting the DTA can considerably benefit drug discovery by narrowing the search space and pruning drug-target (DT) pairs with low binding ...
Junjie Wang   +4 more
doaj   +1 more source

Drug-Target Residence Time Affects in Vivo Target Occupancy through Multiple Pathways

open access: yes, 2019
The drug discovery and development process is greatly hampered by difficulties in translating in vitro potency to in vivo efficacy. Recent studies suggest that the long-neglected drug-target residence time parameter complements classical drug affinity ...
Bruce D. Hammock (65754)   +9 more
core   +1 more source

GEFA: early fusion approach in drug-target affinity prediction

open access: yes, 2022
GEFA: early fusion approach in drug-target affinity ...
Thin Nguyen (13097583)   +3 more
core  

Target engagement of ginsenosides in mild cognitive impairment using mass spectrometry-based drug affinity responsive target stability

open access: yesJournal of Ginseng Research, 2022
Background: Mild cognitive impairment (MCI) is a transitional condition between normality and dementia. Ginseng is known to have effects on attenuating cognitive deficits in neurogenerative diseases.
Zhu Zhu   +8 more
doaj   +1 more source

Discovery of Novel Active Diamidines as Clinical Candidates Against "Trypanosoma Evansi" Infection [PDF]

open access: yes, 2007
The animal pathogenic protozoan, Trypanosoma evansi, leads to a wasting disease in equines, cattle and camels, commonly known as Surra. It is extensively distributed geographically with a wide range of mammalian hosts and causes great economical loss ...
Gillingwater, Kirsten
core   +1 more source

Reciprocal control of viral infection and phosphoinositide dynamics

open access: yesFEBS Letters, EarlyView.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source

DTA+VAE: Drug Target Affinity prediction with SELFIES String via variational autoencoder and Transformer6 protein model

open access: yes, 2023
A crucial step in drug discovery is identifying drug-target interactions. Over the years, there have been many computational methods to determine whether a drug and a target will interact or not.
Patel, Yakin
core  

Home - About - Disclaimer - Privacy